Table 2 Summary of findings.
Outcomes | Relative effect (95% CI) | Number of participants(studies) | Quality of the evidence(GRADE) | Comments |
---|---|---|---|---|
Energy intake | SMD –0.19 decrease with glucagon (–0.59 decrease to 0.21 increase) | 77 participants (5 studies) | ⊕⊕⊝⊝ Lowa | |
Energy expenditure | SMD 0.72 increase with glucagon (0.37 increase to 1.08 increase) | 59 participants (5 studies) | ⊕⊕⊕⊕ High | |
Glucose | SMD 1.11 increase with glucagon (0.60 increase to 1.62 increase) | 159 participants (13 studies) | ⊕⊕⊝⊝ Lowb | Glucose response was not moderated by route of administration or total glucagon dose |
Insulin | SMD 1.33 increase with glucagon (0.88 increase to 1.77 increase) | 147 participants (12 studies) | ⊕⊕⊝⊝ Lowc | Insulin response was not moderated by route of administration or total glucagon dose |